AKT1 and cancer: This could be at least partly explained mechanistically, as in other cancer types, the combinatorial effect of PP2A reactivation has been linked to more efficient shutdown of the kinase pathway, whereas in GB cells, AKT or PDK inhibitors were alone sufficient to completely block the, respectively, signaling pathways.